FDA president and Executive Committee elections 2022
Nominations are now open for the election of the FDA president and members of the FDA Executive Committee. As members of both the FDA and UNISON, MiP members are entitled to stand for election, nominate candidates and vote in both elections.
FDA Executive Committee
The FDA Executive Committee (EC) makes sure that decisions taken at the FDA’s Annual Delegate Conference (ADC) are put into action, meeting with the General Secretary at least six times a year to look after the union’s affairs.
The EC is made up of members elected from various constituencies representing of the breadth of the FDA’s membership.
MiP has four seats on the FDA EC. MiP members can only nominate candidates from within the MiP constituency, and each nomination must be signed by at least two MiP members or by the MiP National Committee. If more than four candidates are nominated, a postal ballot will be held. Members elected to represent the MiP constituency will serve for a two-year term, from 1 June 2020 to 31 May 2022.
You can download the nomination form for the Executive Committee elections here.
FDA President
MiP members can also nominate candidates, from any constituency of the FDA, for the post of the FDA president. Candidates will need at least 30 nominations to stand, including at least five from three different constituencies. If more than one candidate is successfully nominated, a postal ballot will be held. The president will serve a two-year term, from 1 June 2022 to 31 May 2024.
You can download the nomination form for the election of the FDA president here.
Nominations for both elections close at 5pm on Friday 25 March 2022.
You can read more about the FDA’s structure and the role of the president and Executive Committee on the FDA’s website.
Related News
-
Government proposal for sub-inflation pay rise “not good enough”, says MiP
Pay rises for most NHS staff should be restricted to an “affordable” 2.5% next year to deliver improvements to NHS services and avoid “difficult” trade-offs, the UK government has said.
-
Unions refuse to back “grossly unfair” voluntary exit scheme for ICB and NHS England staff
NHS trade unions, including MiP, have refused to endorse NHS England’s national voluntary redundancy (VR) scheme, describing some aspects of the scheme as “grossly unfair” and warning of “potentially serious” tax implications.
-
Urgent action needed retain and recruit senior leaders, says MiP
NHS leaders are experiencing more work-related stress and lower morale, with the government’s sweeping reforms of the NHS in England a major factor, according to a new MiP survey.